Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study

Taoufik M. Alsaadi, Alan Shatzel, Anna Vinter Marquez, Julie Jorgensen, Sarah E Tomaszewski Farias

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

We identified 46 patients with a history of partial seizures, with and without secondarily generalization, who received levetiracetam (LEV) (Keppra®) monotherapy. Patients began LEV either as first line therapy (n = 11) or were converted to LEV monotherapy (n = 35) after failing prior antiepileptic medications (AEDs). Patients were followed up to 12 months after LEV started. The majority of these patients were able to continue on LEV and a small number of patients discontinued LEV secondary to lack of efficacy. One third of the non-seizure free group at 6 months of follow-up had worse seizure control at 12 months and two thirds had the same or better seizure control. Our 1-year follow-up data of LEV as monotherapy suggests that LEV can be effective and well tolerated in adults with either new or difficult to control epilepsy. A prospective, large, long-term double-blind study is needed to confirm this finding.

Original languageEnglish (US)
Pages (from-to)139-142
Number of pages4
JournalSeizure
Volume14
Issue number2
DOIs
StatePublished - Mar 2005

Fingerprint

etiracetam
Epilepsy
Seizures

Keywords

  • Levetiracetam
  • Monotherapy
  • Partial seizures

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Neurology
  • Psychology(all)

Cite this

Clinical experience of levetiracetam monotherapy for adults with epilepsy : 1-year follow-up study. / Alsaadi, Taoufik M.; Shatzel, Alan; Marquez, Anna Vinter; Jorgensen, Julie; Tomaszewski Farias, Sarah E.

In: Seizure, Vol. 14, No. 2, 03.2005, p. 139-142.

Research output: Contribution to journalArticle

Alsaadi, Taoufik M. ; Shatzel, Alan ; Marquez, Anna Vinter ; Jorgensen, Julie ; Tomaszewski Farias, Sarah E. / Clinical experience of levetiracetam monotherapy for adults with epilepsy : 1-year follow-up study. In: Seizure. 2005 ; Vol. 14, No. 2. pp. 139-142.
@article{7edfeb8ac87744e8964da97701afe985,
title = "Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study",
abstract = "We identified 46 patients with a history of partial seizures, with and without secondarily generalization, who received levetiracetam (LEV) (Keppra{\circledR}) monotherapy. Patients began LEV either as first line therapy (n = 11) or were converted to LEV monotherapy (n = 35) after failing prior antiepileptic medications (AEDs). Patients were followed up to 12 months after LEV started. The majority of these patients were able to continue on LEV and a small number of patients discontinued LEV secondary to lack of efficacy. One third of the non-seizure free group at 6 months of follow-up had worse seizure control at 12 months and two thirds had the same or better seizure control. Our 1-year follow-up data of LEV as monotherapy suggests that LEV can be effective and well tolerated in adults with either new or difficult to control epilepsy. A prospective, large, long-term double-blind study is needed to confirm this finding.",
keywords = "Levetiracetam, Monotherapy, Partial seizures",
author = "Alsaadi, {Taoufik M.} and Alan Shatzel and Marquez, {Anna Vinter} and Julie Jorgensen and {Tomaszewski Farias}, {Sarah E}",
year = "2005",
month = "3",
doi = "10.1016/j.seizure.2004.12.006",
language = "English (US)",
volume = "14",
pages = "139--142",
journal = "Seizure : the journal of the British Epilepsy Association",
issn = "1059-1311",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Clinical experience of levetiracetam monotherapy for adults with epilepsy

T2 - 1-year follow-up study

AU - Alsaadi, Taoufik M.

AU - Shatzel, Alan

AU - Marquez, Anna Vinter

AU - Jorgensen, Julie

AU - Tomaszewski Farias, Sarah E

PY - 2005/3

Y1 - 2005/3

N2 - We identified 46 patients with a history of partial seizures, with and without secondarily generalization, who received levetiracetam (LEV) (Keppra®) monotherapy. Patients began LEV either as first line therapy (n = 11) or were converted to LEV monotherapy (n = 35) after failing prior antiepileptic medications (AEDs). Patients were followed up to 12 months after LEV started. The majority of these patients were able to continue on LEV and a small number of patients discontinued LEV secondary to lack of efficacy. One third of the non-seizure free group at 6 months of follow-up had worse seizure control at 12 months and two thirds had the same or better seizure control. Our 1-year follow-up data of LEV as monotherapy suggests that LEV can be effective and well tolerated in adults with either new or difficult to control epilepsy. A prospective, large, long-term double-blind study is needed to confirm this finding.

AB - We identified 46 patients with a history of partial seizures, with and without secondarily generalization, who received levetiracetam (LEV) (Keppra®) monotherapy. Patients began LEV either as first line therapy (n = 11) or were converted to LEV monotherapy (n = 35) after failing prior antiepileptic medications (AEDs). Patients were followed up to 12 months after LEV started. The majority of these patients were able to continue on LEV and a small number of patients discontinued LEV secondary to lack of efficacy. One third of the non-seizure free group at 6 months of follow-up had worse seizure control at 12 months and two thirds had the same or better seizure control. Our 1-year follow-up data of LEV as monotherapy suggests that LEV can be effective and well tolerated in adults with either new or difficult to control epilepsy. A prospective, large, long-term double-blind study is needed to confirm this finding.

KW - Levetiracetam

KW - Monotherapy

KW - Partial seizures

UR - http://www.scopus.com/inward/record.url?scp=13444269601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13444269601&partnerID=8YFLogxK

U2 - 10.1016/j.seizure.2004.12.006

DO - 10.1016/j.seizure.2004.12.006

M3 - Article

C2 - 15694569

AN - SCOPUS:13444269601

VL - 14

SP - 139

EP - 142

JO - Seizure : the journal of the British Epilepsy Association

JF - Seizure : the journal of the British Epilepsy Association

SN - 1059-1311

IS - 2

ER -